Insulet (PODD) Tops Q3 EPS by 34c; offers guidance

Insulet (NASDAQ: PODD) reported Q3 EPS of $0.74, $0.34 better than the analyst estimate of $0.40. Revenue for the quarter came in at $432.7 million versus the consensus estimate of $414.32 million.

For the year ending December 31, 2023, the Company is raising its expected revenue growth to a range of 26% to 27% (previously 22% to 25%).

For earnings history and earnings-related data on Insulet (PODD) click here.

You May Also Be Interested In

• Sprinklr (CXM) Tops Q2 EPS by 1c, Offers Guidance
• Important Notice to Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); Flotek Industries, Inc. (NYSE: FTK); Hub Group, Inc. (NASDAQ: HUBG); and Insulet Corporation (NASDAQ: PODD): G
• Important Notice to Long-Term Shareholders of Hub Group, Inc. (NASDAQ: HUBG); Hyliion Holdings Corp. (NYSE: HYLN); Insulet Corporation (NASDAQ: PODD); and York Space Systems Inc. (NYSE: YSS): Grabar L